Relevant bibliographies by topics / Tong xing lian

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters

Academic literature on the topic 'Tong xing lian'

Author: Grafiati
Published: 4 June 2021
Last updated: 27 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Tong xing lian.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Tong xing lian"

1

Yang, Meng-Yue, Zhao-Xiang Shao, Yue-Tong Wang, et al. "Stilbenes with potent cytotoxicity from the seedcases of Paeonia suffruticosa Andrews." Phytochemistry 205 (January 31, 2023): 1–9. https://doi.org/10.1016/j.phytochem.2022.113515.

Full text
Abstract:
Yang, Meng-Yue, Shao, Zhao-Xiang, Wang, Yue-Tong, Hou, Yong-Lian, Zhu, Ding-Kang, Chen, Sha, Zhang, Ya-Hui, Cao, Fei, Jing, Yong-Kui, Lin, Bin, Li, Zhan-Lin, Li, Da-Hong, Hua, Hui-Ming (2023): Stilbenes with potent cytotoxicity from the seedcases of Paeonia suffruticosa Andrews. Phytochemistry (113515) 205: 1-9, DOI: 10.1016/j.phytochem.2022.113515, URL: http://dx.doi.org/10.1016/j.phytochem.2022.113515
APA, Harvard, Vancouver, ISO, and other styles
2

HUANG, DI-YING, YI-TONG SU, XIN-NENG LIAN, and JIAN GAO. "Fossil caddis cases from the lower Eocene Huachong Formation of the Sanshui Basin, Foshan City, Guangdong Province, South China with detrital zircon analyses." Palaeoentomology 5, no. 2 (2022): 105–12. https://doi.org/10.11646/palaeoentomology.5.2.2.

Full text
Abstract:
HUANG, DI-YING, SU, YI-TONG, LIAN, XIN-NENG, GAO, JIAN (2022): Fossil caddis cases from the lower Eocene Huachong Formation of the Sanshui Basin, Foshan City, Guangdong Province, South China with detrital zircon analyses. Palaeoentomology 5 (2): 105-112, DOI: 10.11646/palaeoentomology.5.2.2, URL: http://dx.doi.org/10.11646/palaeoentomology.5.2.2
APA, Harvard, Vancouver, ISO, and other styles
3

Peng, Yu-Lan, Yu Zhang, Xin-Fen Gao, et al. "A phylogenetic analysis and new delimitation of Crepidiastrum (Asteraceae, tribe Cichorieae)." Phytotaxa 159, no. 4 (2014): 241–55. https://doi.org/10.11646/phytotaxa.159.4.1.

Full text
Abstract:
Peng, Yu-Lan, Zhang, Yu, Gao, Xin-Fen, Tong, Lin-Jing, Li, Liang, Li, Ren-Yuan, Zhu, Zhang-Ming, Xian, Jun-Ren (2014): A phylogenetic analysis and new delimitation of Crepidiastrum (Asteraceae, tribe Cichorieae). Phytotaxa 159 (4): 241-255, DOI: 10.11646/phytotaxa.159.4.1, URL: http://dx.doi.org/10.11646/phytotaxa.159.4.1
APA, Harvard, Vancouver, ISO, and other styles
4

Zhang, Xin, Qianqian Lian, Qian Qian, et al. "Abstract 5917: A novel ROR1 antibody with high specificity and sensitivity for predictive biomarker detection in various tumor types." Cancer Research 85, no. 8_Supplement_1 (2025): 5917. https://doi.org/10.1158/1538-7445.am2025-5917.

Full text
Abstract:
Abstract ROR1, a receptor tyrosine kinase-like orphan receptor, is a key mediator of non-canonical Wnt signaling and plays a critical role in cancer progression. ROR1 is selectively and highly expressed in various solid tumors and hematological malignancies while absent in normal adult tissues, making it a promising target for cancer therapy. Despite this potential, the lack of effective tools has hindered sensitive detection of ROR1 in patient tumor samples by IHC. To address this, we have developed a recombinant rabbit monoclonal antibody in-house, demonstrating superior sensitivity and spec
APA, Harvard, Vancouver, ISO, and other styles
5

Li, Zhuo, Liang Qu, Xin Chen, et al. "Abstract 2371: BGB-B167, a first-in-class 4-1BB/CEACAM5 bispecific antibody, exhibits potent in vitro and < for vivo antitumor activity and < for superior safety profile in preclinical models." Cancer Research 84, no. 6_Supplement (2024): 2371. http://dx.doi.org/10.1158/1538-7445.am2024-2371.

Full text
Abstract:
Abstract 4-1BB (CD137) is a key costimulatory immunoreceptor and a promising therapeutic target in cancer. CEACAM5 (CEA) is a well-established tumor associated antigen overexpressed in many cancers, including colorectal, gastric, lung, pancreatic cancer, liver, breast and thyroid cancers. BGB-B167 is a novel immunoglobulin G (IgG)-based bispecific antibody targeting 4-1BB and CEA and is under clinical development for the treatment of advanced or metastatic solid tumors in humans. BGB-B167 binds to its target proteins with high specificity and affinity. Potent and CEA-dependent functional activ
APA, Harvard, Vancouver, ISO, and other styles
6

Meng, Jie, Ming Chang, Siyuan Qin, et al. "Abstract 5387: Host-derived CCL2 drives prostate cancer bone metastasis via CCND2/STAT3 pathway." Cancer Research 84, no. 6_Supplement (2024): 5387. http://dx.doi.org/10.1158/1538-7445.am2024-5387.

Full text
Abstract:
Abstract Overexpression of tumor-derived CCL2 has been shown to partially promote prostate cancer (PCa) bone metastasis, but the function of host-derived CCL2 is not fully understood. We first developed a mouse model using intracardiac injection and obtained highly metastatic PCa cell subclones through in vivo selection. The highly metastatic tumor cells were injected intracardially into CCL2 knockout (CCL2 KO) mice and wild-type (WT) controls, and the tumor cell growth and metastasis were monitored weekly by bioluminescence imaging. The osteolytic lesions were evaluated by radiography, micro-
APA, Harvard, Vancouver, ISO, and other styles
7

Liang, Haixi, Tong Xiang, Lin Zhou, Zhiwen Xie, Mao Ye, and Chunyan Lan. "Abstract 3550: Dendritic cells pulsed with cancer stem cell antigen showed profound anti-tumoral efficacy in ovarian cancer." Cancer Research 85, no. 8_Supplement_1 (2025): 3550. https://doi.org/10.1158/1538-7445.am2025-3550.

Full text
Abstract:
Abstract Background: Ovarian cancer serves as the first leading lethally gynecologic cancer, of which around 70% of patients would relapse soon even have undergone standard treatment. Several mechanisms work together attributing to the early relapse. Among these, cancer stem cells (CSCs) act as the root of metastasis and relapse in the early reports. However, limited methods directly targeting these rare populations have been developed so far. Here we develop DC vaccine directly targeting CSCs by loading DCs with enriched cancer stem cell antigen (CSC-Ag) in vitro. Methods: Freshly dissected o
APA, Harvard, Vancouver, ISO, and other styles
8

Zhou, Lin, Haixi Liang, Zhiwen Xie, et al. "Abstract CT030: Mesothelin-targeted CAR-T therapy FC004 for platinum-resistant ovarian cancer: A phase I trial." Cancer Research 85, no. 8_Supplement_2 (2025): CT030. https://doi.org/10.1158/1538-7445.am2025-ct030.

Full text
Abstract:
Abstract Background: Platinum-resistant is a highly aggressive gynecological malignancy with limited treatment options. Mesothelin (MSLN), overexpressed in ovarian cancer cells, is a promising target for chimeric antigen receptor (CAR) T-cell therapy. Recent evidence shows that MSLN-CAR T cells can recognize and attack cancer cells, offering a potential new treatment for platinum-resistant ovarian cancer. We report results from a phase I study of FC004, an MSLN-CAR T-cell therapy, in patients with platinum-resistant ovarian cancer. Methods: Eligible patients were aged 18-75 years, with histolo
APA, Harvard, Vancouver, ISO, and other styles
9

Yin, Yongmei, Xinhong Wu, Quchang Ouyang, et al. "Abstract PS08-08: Updated efficacy and safety of SKB264 (MK-2870) for previously treated metastatic triple negative breast cancer (mTNBC) in Phase 2 study." Cancer Research 84, no. 9_Supplement (2024): PS08–08—PS08–08. http://dx.doi.org/10.1158/1538-7445.sabcs23-ps08-08.

Full text
Abstract:
Abstract Background: Patients (pts) with mTNBC have limited treatment options and poor prognosis. The estimated median overall survival (OS) of pts with mTNBC is 12 to 18 months (mo) after diagnosis. SKB264, an antibody drug conjugate (ADC) composed of an anti-TROP2 antibody coupled to a cytotoxic belotecan-derivative via a novel linker with an average Drug to Antibody Ratio (DAR) of 7.4, has shown promising anti-tumor activity and tolerable safety profile in pts with mTNBC (Yin, Y. et al. SABCS 2022). Here, we report the updated data from a Phase 2 expansion cohort for pts with mTNBC (NCT0415
APA, Harvard, Vancouver, ISO, and other styles
10

Zhu, Xiu-Zhi, Xi Jin, Hu-Yun-Long Zhang, et al. "Abstract PO1-15-07: Subtyping-directed precision treatment refines traditional one-size-fits-all therapy in HR+/HER2- breast cancer: a sub-study of the MULAN umbrella trial." Cancer Research 84, no. 9_Supplement (2024): PO1–15–07—PO1–15–07. http://dx.doi.org/10.1158/1538-7445.sabcs23-po1-15-07.

Full text
Abstract:
Abstract Background: The standard approach of using one-size-fits-all endocrine therapy for hormone receptor-positive and HER2-negative (HR+/HER2-) breast cancers has faced significant challenges due to variations in treatment response among individuals. Consequently, there is still an urgent need to understand the molecular biology of HR+/HER2- breast cancer and explore precision treatment strategy. Methods: We established a multiomics cohort (n = 351), multicenter real-world clinical cohorts (n = 643), a prospective clinical cohort (MULAN trial), and a drug-testing platform containing patien
APA, Harvard, Vancouver, ISO, and other styles

Dissertations / Theses on the topic "Tong xing lian"

1

Ma, Yihua. "Zhong yi yao zhi liao tong jing (yuan fa xing tong jing) de wen xian yan jiu /." click here to view the abstract and table of contents, 2006. http://net3.hkbu.edu.hk/~libres/cgi-bin/thesisab.pl?pdf=b1998747xa.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Tong xing lian"

1

1935-, Li Ao, ed. Tong xing, tong xing, tong xing lian. Tian yuan tu shu you xian gong si, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Niunairen, ed. Wo shi tong xing lian. Hua ren ban tu wen hua shi ye you xian gong si, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Dalin, Liu, and Lu Longguang, eds. Zhongguo tong xing lian yan jiu. Zhongguo she hui chu ban she, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Ge, Bing. Da lian mao he mo xing za ji tuan. Bei jing jiao yu chu ban she, 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Po, Meishu, and Enying Jiang. Ni shi han xing, Ni tong xue zhi dao ma. Xin shi ji chu ban she, 2014.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

sheng, Yu hai, and Shi te lao si. Ba mei da ren sheng jing. Zhong guo san jia chu ban she, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

jia, Zhao hong, and Liu ying. Nei xin xiu lian qi zhi nü ren. Ha er bin chu ban she, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Shangwei, Lin, ed. Wang luo bian lian tong xing de zui you hua. Ke xue chu ban she, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

An, Zi. Lian ai jue ding nü ren de yi sheng. Jin cheng chu ban she, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Gelei. Nan ren lai zi huo xing, Nü ren lai zi jin xing: Jing hua man hua ban. Zhong xin chu ban she, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Tong xing lian"

1

Taber, Douglass F. "Enantioselective Preparation of Alcohols and Amines: The Lam Synthesis of (+)-Tanikolide." In Organic Synthesis. Oxford University Press, 2013. http://dx.doi.org/10.1093/oso/9780199965724.003.0038.

Full text
Abstract:
Takashi Ooi of Nagoya University effected (J. Am. Chem. Soc. 2010, 132, 12240) the enantioselective protonation of ketene silyl acetals such as 1 to give 2 in high ee. Hyeon-Kyu Lee of the Korean Research Institute of Chemical Technology achieved (Org. Lett. 2010, 12, 4184) high ee in the hydrogenation of the cyclic sulfamidate 3 to 4. Doo Ok Jang of Yonsei University combined (J. Am. Chem. Soc. 2010, 132, 12168) the nucleophilic allyl indium with a protonated chiral amine to effect homologation of 5 to 6. Ryo Shintani and Tamio Hayashi of Kyoto University reported (Org. Lett. 2010, 12, 4106)
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Tong xing lian' for particular source types:
Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography